Susquehanna International Group’s Bone Biologics Corp Warrants BBLGW Stock Holding History

Susquehanna International Group’s Portfolio BBLGW Stock Details BBLGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-862	Closed	-$1.03K	–	12052
2023 Q1	$1.03K	Buy	+862	New	+$1.18K	﹤0.01%	12415

Other funds holding BBLGW

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's BBLGW Position: Q2 2023 in Review

Susquehanna International Group sold out of Bone Biologics Corp Warrants (BBLGW) in Q2 2023, closing a stake of 862 shares — an estimated $1.03K sold.

Susquehanna International Group first reported a position in BBLGW in Q1 2023 and held it in 1 quarter. The position peaked at $1.03K in Q1 2023. 1 fund tracked by Wall St. Rank holds BBLGW as of Q2 2023.

Susquehanna International Group reported no remaining Bone Biologics Corp Warrants position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 862 Bone Biologics Corp Warrants shares in Q2 2023, an estimated $1.03K.
Susquehanna International Group first reported a position in Bone Biologics Corp Warrants in Q1 2023 and held it in 1 quarter.
Susquehanna International Group's Bone Biologics Corp Warrants position peaked at $1.03K in Q1 2023.
1 fund tracked by Wall St. Rank held Bone Biologics Corp Warrants as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.